glucagon has been researched along with Leanness in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.35) | 18.7374 |
| 1990's | 3 (13.04) | 18.2507 |
| 2000's | 8 (34.78) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 4 (17.39) | 2.80 |
| Authors | Studies |
|---|---|
| Ellingsgaard, H; Karstoft, K; Klarlund Pedersen, B; Peletier, M; Plomgaard, P; Simonsen, C; Trinh, B; van Hall, G | 1 |
| Argyrakopoulou, G; Kalra, B; Kokkinos, A; Konstantinidou, SK; Kouvari, M; Kumar, A; Mantzoros, CS; Simati, S; Stefanakis, K | 1 |
| Cao, X; Han, X; Huang, WY; Jia, W; Li, J; Peng, S; Peng, Y; Wang, L; Xu, Y; Ye, J; Ye, X; Zhang, S; Zhang, X; Zhou, Y | 1 |
| Allerton, DM; Bowden Davies, KA; Brunsgaard, LH; Smith, K; Stevenson, EJ; Taylor, GS; West, DJ | 1 |
| Gribble, FM; Hardwick, RH; Howard, J; Kay, RG; Reimann, F; Roberts, GP | 1 |
| Charron, MJ; Du, XQ; Foda, ZH; Kleiner, RE; Leissring, MA; Liu, DR; Maianti, JP; McFedries, A; Saghatelian, A; Seeliger, MA; Tang, WJ | 1 |
| Caldwell, D; Chen, Q; Coughlan, MC; Florian, M; Fu, A; Jin, X; Lalande, M; Laziyan, M; Mailloux, R; Patry, D; Petrov, I; Wang, GS; Willmore, W; Yan, J | 1 |
| Carlson, OD; Egan, JM; Elahi, D; Habener, JF; Meneilly, GS; Ruff, DA | 1 |
| Hara, K; Kaku, H; Kato, T; Mitsuzaki, K; Muraishi, K; Nakayama, H; Nakayama, S; Ohki, T; Tajiri, Y; Tanaka, K; Tokubuchi, I; Tsuruta, M; Wada, N; Yamada, K | 1 |
| Blackwood, A; Farooqi, IS; Greenfield, JR; Gribble, FM; Habib, AM; Henning, E; Holst, JJ; Keogh, JM; Reimann, F | 1 |
| Ackermans, MT; Duran, M; Faas, L; Fliers, E; Houten, SM; Ruiter, AF; Sauerwein, HP; Serlie, MJ; Smeenge, M; Soeters, MR; Wanders, RJ | 1 |
| Haltia, LT; Kaasinen, V; Rinne, JO; Savontaus, E; Vahlberg, T | 1 |
| Chen, G; Chen, W; Ge, Y; Li, R; Li, Y; Zhang, Y | 1 |
| Chapman, IM; Feinle, C; Horowitz, M; Wishart, J | 1 |
| Astrup, A; Feldt-Rasmussen, U; Holst, JJ; Mersebach, H; Svendsen, OL | 1 |
| Donahue, EP; Fujimoto, Y; Shiota, M | 1 |
| Adam, TC; Westerterp-Plantenga, MS | 1 |
| Casals, MM; Clark, WS; Gebhart, SP; Mixon, PS; Phillips, LS; Umpierrez, GE | 1 |
| Assimacopoulos-Jeannet, F; Felber, JP; Jeanrenaud, B; Jéquier, E; Mosimann, F; Müller, C; Pachiaudi, C; Riou, JP; Schneiter, P; Tappy, L | 1 |
| Ito, C | 1 |
| Hellerstein, MK; Hirsch, J; Hudgins, LC; Neese, RA; Seidman, CE; Tremaroli, JD | 1 |
| Buckingham, RE; Lister, CA; Smith, SA; Toseland, CD | 1 |
| Eaton, RP; Simonelli, C | 1 |
1 review(s) available for glucagon and Leanness
| Article | Year |
|---|---|
[Leanness and diabetes mellitus].
Topics: Biomarkers; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Nutritional Status; Protein Precursors; Thinness | 1997 |
6 trial(s) available for glucagon and Leanness
| Article | Year |
|---|---|
Blocking endogenous IL-6 impairs mobilization of free fatty acids during rest and exercise in lean and obese men.
Topics: Adult; Antibodies, Monoclonal, Humanized; Carbohydrates; Exercise; Fatty Acids; Glucagon; Glucose; Humans; Hydrocortisone; Interleukin-6; Kinetics; Lipolysis; Obesity; Oxidation-Reduction; Receptors, Interleukin-6; Rest; Thinness | 2021 |
The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Eating; England; Food, Formulated; Gastric Emptying; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Middle Aged; Obesity, Abdominal; Postprandial Period; Thinness; Whey Proteins; Young Adult | 2021 |
Does GLP-1 suppress its own basal secretion?
Topics: Adult; Basal Metabolism; Blood Glucose; Feedback, Physiological; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Obesity; Peptide Fragments; Peptides; Thinness | 2016 |
Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects.
Topics: Administration, Oral; Adult; Area Under Curve; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glutamine; Humans; Insulin; Insulin Secretion; Male; Obesity; Thinness | 2009 |
Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.
Topics: Adolescent; Adult; Dietary Fats; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Male; Obesity; Peptide Fragments; Protein Precursors; Thinness | 2002 |
Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Cholesterol, HDL; Dietary Carbohydrates; Dietary Fats; Eating; Energy Metabolism; Fasting; Fatty Acids; Female; Glucagon; Humans; Hypertriglyceridemia; Insulin; Lipoproteins, VLDL; Male; Middle Aged; Obesity; Thinness; Triglycerides | 2000 |
16 other study(ies) available for glucagon and Leanness
| Article | Year |
|---|---|
Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals.
Topics: Blood Glucose; Female; Glicentin; Glucagon; Humans; Male; Meals; Obesity; Peptides; Postprandial Period; Proglucagon; Thinness | 2023 |
ADP Induces Blood Glucose Through Direct and Indirect Mechanisms in Promotion of Hepatic Gluconeogenesis by Elevation of NADH.
Topics: Adenosine Diphosphate; Animals; Diet; Glucagon; Gluconeogenesis; Glucose; Liver; Male; Mice; Mice, Inbred C57BL; NAD; Obesity; Signal Transduction; Thinness | 2021 |
Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery.
Topics: Adult; Bariatric Surgery; Blood Glucose; Case-Control Studies; Female; Gastrectomy; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Male; Peptide YY; Proglucagon; Thinness | 2018 |
Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
Topics: Animals; Binding Sites; Blood Glucose; Catalytic Domain; Diabetes Mellitus, Type 2; Disease Models, Animal; Gastric Emptying; Genetic Predisposition to Disease; Glucagon; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulysin; Islet Amyloid Polypeptide; Macrocyclic Compounds; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Obesity; Signal Transduction; Thinness | 2014 |
A Northern contaminant mixture impairs pancreas function in obese and lean JCR rats and inhibits insulin secretion in MIN6 cells.
Topics: Alcohol Drinking; Animals; Cell Death; Cell Line, Tumor; Complex Mixtures; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Environmental Pollutants; Glucagon; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Male; Mice; Mitochondria; Obesity; Oxidative Stress; Pancreatic Neoplasms; Rats; Risk Assessment; Thinness | 2015 |
Cross-sectional and Longitudinal Analyses of Factors Contributing to the Progressive Loss of the β-cell Function in Type 2 Diabetes.
Topics: Adult; Aged; Body Mass Index; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Longitudinal Studies; Male; Middle Aged; Overweight; Regression Analysis; Thinness; Triglycerides | 2015 |
Effects of insulin on ketogenesis following fasting in lean and obese men.
Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; Body Weight; Energy Metabolism; Epinephrine; Fasting; Fatty Acids, Nonesterified; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Resistance; Ketone Bodies; Male; Middle Aged; Obesity; Thinness; Young Adult | 2009 |
Acute hormonal changes following intravenous glucose challenge in lean and obese human subjects.
Topics: Adult; Blood Glucose; Fatty Acids, Nonesterified; Female; Ghrelin; Glucagon; Glucose; Glucose Tolerance Test; Hormones; Humans; Injections, Intravenous; Insulin; Leptin; Male; Obesity; Peptide YY; Thinness; Young Adult | 2010 |
Insulin-regulated Srebp-1c and Pck1 mRNA expression in primary hepatocytes from zucker fatty but not lean rats is affected by feeding conditions.
Topics: Animals; Cell Separation; Cells, Cultured; Cholesterol; fas Receptor; Fasting; Feeding Behavior; Gene Expression Regulation; Glucagon; Hepatocytes; Insulin; Male; Phosphoenolpyruvate Carboxykinase (GTP); Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Zucker; Receptor, Insulin; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Thinness | 2011 |
Comparisons of leptin, incretins and body composition in obese and lean patients with hypopituitarism and healthy individuals.
Topics: Adult; Anthropometry; Body Composition; Case-Control Studies; Cross-Sectional Studies; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Human Growth Hormone; Humans; Hypopituitarism; Leptin; Lipids; Male; Middle Aged; Obesity; Peptide Fragments; Peptides; Thinness | 2003 |
Defect in glucokinase translocation in Zucker diabetic fatty rats.
Topics: Animals; Biological Transport; Blood Glucose; Carrier Proteins; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Glucokinase; Glucose; Glucose-6-Phosphate; Glycogen; Insulin; Intracellular Membranes; Intracellular Signaling Peptides and Proteins; Liver; Male; Muscle, Skeletal; Obesity; Rats; Rats, Zucker; Thinness; Tissue Distribution | 2004 |
Activity-induced GLP-1 release in lean and obese subjects.
Topics: Adult; Analysis of Variance; Area Under Curve; Basal Metabolism; Blood Glucose; Enzyme-Linked Immunosorbent Assay; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Motor Activity; Obesity; Peptide Fragments; Protein Precursors; Thinness; Weight Loss | 2004 |
Diabetic ketoacidosis in obese African-Americans.
Topics: Adult; Black People; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Georgia; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Reference Values; Thinness | 1995 |
Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients.
Topics: Adult; Aged; Biopsy; Blood Glucose; Body Mass Index; Carbon Isotopes; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Liver; Liver Glycogen; Male; Middle Aged; Models, Biological; Obesity; Reference Values; Thinness | 1997 |
Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.
Topics: Aging; Animals; Cataract; Diabetes Mellitus, Type 2; Glucagon; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Pancreas; Proteinuria; Rats; Rats, Zucker; Rosiglitazone; Thiazoles; Thiazolidinediones; Thinness; Thirst; Time Factors | 2000 |
Reduced triglyceride secretion: a metabolic consequence of chronic exercise.
Topics: Animals; Body Weight; Disease Models, Animal; Female; Glucagon; Hyperlipidemias; Insulin; Lipid Metabolism; Liver; Obesity; Physical Exertion; Rats; Rats, Inbred Strains; Thinness; Triglycerides | 1978 |